Other
Post-Surgical
0
Pipeline Programs↗
6
Active Trials↗
2
Companies Involved↗
Post-surgical is an early-stage landscape with 0 programs across 2 companies. The most active players are Pfizer, Endo Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
23
clinical trials
Completed11 · 48%
Recruiting4 · 17%
Unknown status3 · 13%
Terminated2 · 9%
Active, not recruiting2 · 9%
Withdrawn1 · 4%
Clinical Trials
Trial Activity
23 trials
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Active, not recruiting·—·Phase 3·NCT03104517·96 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)